Product introduction:
Tofacitinib citrate is a JAK kinase inhibitor for the treatment of rheumatoid arthritis. It is used for moderate to severe active rheumatoid arthritis with insufficient or intolerable response to methotrexate treatment.
CAS:540737-29-9
Molecular formula: C16H20N6O.C6H8O7
Molecular weight: 504.497
Structural type:
Product purpose: Tofacitinib citrate combined with methotrexate is used to treat active rheumatoid arthritis with insufficient response to tumor necrosis factor inhibitors.